Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8441513 | European Journal of Cancer | 2016 | 10 Pages |
Abstract
Radiotherapy used for the treatment of HNRMS confers a significant risk of the development of pituitary dysfunction. AMORE-based treatment in children with HNRMS resulted in less pituitary dysfunction than treatment with conventional EBRT. Our findings underscore the importance of routine early endocrine follow-up in this specific population.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
S.C. Clement, R.A. Schoot, O. Slater, J.C. Chisholm, C. Abela, A.J.M. Balm, M.W. van den Brekel, W.B. Breunis, Y.C. Chang, R. Davila Fajardo, D. Dunaway, E. Gajdosova, M.N. Gaze, S. Gupta, B. Hartley, L.C.M. Kremer, M. van Lennep, G.A. Levitt,